Difference between revisions of "Team:EPF Lausanne/Project/Description"

Line 1: Line 1:
{{:Team:EPF_Lausanne/Top_Nav}}
+
{{:Team:EPF_Lausanne/Test/Top_Nav}}
 
<html>
 
<html>
 
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"-->
 
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"-->
Line 8: Line 8:
 
     <div class="row">
 
     <div class="row">
 
       <div class="col-md-12 text-center">
 
       <div class="col-md-12 text-center">
         <h3>DESCRIPTION</h3>
+
         <h3>Project description</h3>
 
       </div>
 
       </div>
 
     </div>
 
     </div>
Line 14: Line 14:
 
</div>
 
</div>
  
<div class="description-section">
 
  <div class="container">
 
    <div class="row">
 
      <div class="col-md-10 col-md-offset-1">
 
          <h1>Biologic Orthogonal GRNA-Implemented Circuit</h1>
 
          <p>This summer, the EPFL iGEM team strives to pave the way for simpler implementation of digital circuits in vivo. Using the newly discovered dCas9 as a synthetic transcription factor, we aim to design biocompatible transistor-like elements. Our ultimate goal is to make cells smarters by assembling these transistors into logic gates that are both chainable and parallelizable in a homogenous logic framework.</p>
 
          <h2>Thinking Binary</h2>
 
          <p>Boolean Logic is the bedrock of the digital revolution. Developed by George Boole in the mid-19th century, it is based on a simple set of values: 0 (“FALSE”) or 1 (“TRUE”). Modern computers represent all forms of information using strings of the same 0s and 1s (also named “Bits”). The processing of bits is handled by logical transistors - which can be seen as electronically controllable switches. Elementary logic operation are performed using cleverly assembled transistors. Such assemblies are named “logic gates”. Gates are the bricks with which complex behaviour is produced.</p>
 
          <h2>Biological computers</h2>
 
          <p>Since the early 2000’s, multiple synthetic biological gates have been built, revolutionizing our ability to dictate the way organisms react to stimuli. Their applications range from intelligent biosensors to cellular therapeutics with improved in vivo targeting and curing.<br>
 
          Unfortunately, the development of programmable cells has been hampered by difficulties in the multiplication and chaining of logic elements. This has hindered the complexification of bio-circuits as well as the automation and flexibility of their design.<br>
 
          To overcome these limitations, an ideal in vivo logic element should be modular, reusable, and orthogonal - i.e avoiding unwanted cross-talk with its host organism as well as other elements of the engineered circuit.</p>
 
          <h2>Cas9 Logic Gates</h2>
 
          <p>Cas9 (CRISPR associated protein 9) is an RNA-guided DNA endonuclease that targets and cleaves any DNA sequence complementary to its guide RNA (gRNA). Our project will be based upon a derivative of this technology : catalytically “dead” Cas9 (dCas9) that lack the ability to cleave DNA. When fused to a RNA polymerase (RNAP) recruiting element (e.g. the omega subunit of RNAP in E. Coli or VP64 in eukaryotes), chimeric dCas9 can act as a  programmable transcription activator. In addition, activating dCas9 may also act as a DNA transcription inhibitor: depending on its gRNA-determined binding site, it has been shown in yeasts to sterically hinder RNAP recruitment to promoter sequences.<br>
 
          Exploiting dCas9-omega/VP64’s ambivalence, we propose the creation of gRNA-controlled switch-like elements analogous to transistors. The state of the switch would be solely dependent on the position of dCas9 relative to the promoter. The content of the gRNA-targeted sequences might therefore be designed such that each transistor is orthogonal to other logic elements. Using gRNA to make what could be seen as “biological wires”,  we also hope to achieve chainability of the transistors and thus complexification of bio-circuits.</p>
 
      </div>
 
    </div>
 
  </div>
 
</div>
 
  
 
<div class="container">
 
<div class="container">
Line 44: Line 25:
 
   <div class="tab-content background-section">
 
   <div class="tab-content background-section">
 
     <div id="BioLOGIC" class="tab-pane fade in active">
 
     <div id="BioLOGIC" class="tab-pane fade in active">
       <h3>Bio LOGIC in 10 questions</h3>
+
       <h1>Bio LOGIC in 12 questions</h1>
       <p></p>
+
      <h2>What does Bio LOGIC stand for?</h2>
 +
       <p>It stands for “Bio Logic Orthogonal gRNA-Implemented Circuit”. In a few words, we are working on implementing digital-like circuits in cells. This would basically allow intracellular computing.</p>
 +
 
 +
      <h2>Don’t biological circuits already exist?</h2>
 +
      <p>Yes. However, difficulties in the multiplication and chaining of logic elements has hindered the complexification of these circuits. To overcome these limitations, an ideal in vivo logic element should be modular, reusable and orthogonal - i.e avoiding cross-talk with its host organism and the other elements of the circuit.</p>
 +
 
 +
      <h2>So, what’s different about your system?</h2>
 +
      <p>We can avoid some of these issues by making a completely synthetic biological circuit. This is what we are doing by using the newly discovered dCas9 as a synthetic transcription factor.</p>
 +
 
 +
      <h2>How can dCas9 be used as a transcription factor?</h2>
 +
      <p>Well, you know CRISPR-Cas9, the RNA-guided DNA endonuclease, right? We are using dCas9, the catalytically dead version of Cas9, which lacks the ability to cleave DNA. We will fuse dCas9 to a RNA Polymerase (RNAP) recruiting element. Depending on where it binds, this complex will either activate or inhibit transcription.</p>
 +
 
 +
      <h2>How does this activation/inhibition system work?</h2>
 +
      <p>When dCas9 binds at an optimal distance upstream from the promoter, the RNAP recruiting elements with which it is fused will, in fact, recruit RNAP, thus activating the transcription of the gene that is controlled by this promoter. However, when dCas9 binds on the promoter, it will sterically hinder RNAP from binding at the transcription start site, thus inhibiting the transcription of the gene.</p>
 +
 
 +
      <h2>How do you guide the dCas9 to activating/inhibiting region?</h2>
 +
      <p>dCas9 works just like Cas9, meaning it is RNA-guided. Small guide RNA (sgRNA) and dCas9 can form a complex. This complex will bind tightly to a DNA sequence which is complementary to the sgRNA. So we can guide dCas9 to activating or inhibiting regions of a promoter by producing sgRNAs complementary to these sequences.</p>
 +
 
 +
      <h2>Can a sgRNA-dCas9 complex activate one region and inhibit another in the same cell?</h2>
 +
      <p>Yes, a sgRNA-dCas9 complex will bind to any sequence that is complementary to the sgRNA. So, if the activating region and the inhibiting region of different promoters have the same sequence, two identical sgRNA-dCas9 complexes can bind both at the same time. This is also why we have to be careful not to target regions that are present in the genome of the host organism, to not interfere with cell’s standard function.</p>
 +
 
 +
      <h2>What happens if the activating region and the inhibiting region of the same promoter are bound by dCas9 at the same time?</h2>
 +
      <p>That is a very good question! It was shown that inhibition is dominant in yeast (S. Cerevisiae) [Tunable and multifunctional eukaryotic transcription factors based on CRISPR/Cas, F. Farzadfard, S. D. Perli, T. K. Lu].This means that, if both activating and inhibiting regions are bound, the transcription of the gene will be inhibited. One goal of our project is to find out if this is also the case in bacteria (E. Coli). We will also test our system in yeast.</p>
 +
 
 +
      <h2>How are you going to use this to make biological circuits?</h2>
 +
      <p>Because of time constraints, we won’t be able to make a real biologic circuit. We aim to make and characterize a biological equivalent to the simplest element in a digital circuit, a transistor. Transistors function like switches for electric current. Our bio-transistors work like switches for the transcription of a gene and can be assembled to form biological circuits.</p>
 +
 
 +
      <h2>What does your bio-transistor look like?</h2>
 +
      <p>The bio-transistor is simply a gene with a promoter. We insert this synthetic sequence in a cell, along with a gene producing dCas9 fused to the RNAP recruiting element and the sequence that produces an sgRNA complementary to either the activating or the inhibiting region of the promoter. dCas9 and the sgRNA are produced, they form a complex which binds to the activating or inhibiting region of the promoter, thus “turning the gene on or off”.</p>
 +
 
 +
      <h2>How do you make biological circuits from bio-transistors?</h2>
 +
      <p>Well, digital circuits are made out of logic gates, elements that perform basic logic functions (AND, OR, NOT, NOR, NAND, XOR, etc.), and logic gates are made out of transistors. Our idea is to assemble our bio-transistors into logic gates. By linking the output of one logic gate to the input of another one, we can make biological circuits that function in the same way as a digital circuit.</p>
 +
 
 +
      <h2>Sounds cool! But what can this be used for?</h2>
 +
      <p>A single transistor is not very useful. However, by assembling a certain number of bio-transistors, we could make complex biological circuits that would have different outputs depending on many inputs. For example, we could make complex biosensors by building a circuit that is activated by the presence of a specific combination of molecules, or that has a different response for different combinations of molecules. This is only one example among the many applications of biological circuits.</p>
 +
 
 +
      <p>Find out more about how we implemented our system in <a href="#design-ecoli">E. coli</a> and in <a href="#design-yeast">S. cerevisiae</a> or about <a href="#background">what’s already been done with biological circuits and the publications that inspired us</a>, or check out our <a href="https://2015.igem.org/Team:EPF_Lausanne/Results">results</a>.</p>
 +
 
 +
 
 
     </div>
 
     </div>
  
 
     <div id="design-ecoli" class="tab-pane fade">
 
     <div id="design-ecoli" class="tab-pane fade">
 
       <h3>Design in E. Coli</h3>
 
       <h3>Design in E. Coli</h3>
 +
      <p>To implement Bio LOGIC, we need to use dCas9 fused to a RNAP recruiting element. Based on Bikard [reference here], we fused the w (omega) subunit of RNAP to dCas9.
 +
      <h2>The "transcription factor": dCas9-w</h2>
 
       <p></p>
 
       <p></p>
 
     </div>
 
     </div>
Line 65: Line 86:
 
   </div>
 
   </div>
  
  <ul class="nav nav-tabs nav-justified">
 
    <li class="active"><a data-toggle="tab" href="#BioLOGIC">Bio LOGIC</a></li>
 
    <li><a data-toggle="tab" href="#design-ecoli">Design in E. Coli</a></li>
 
    <li><a data-toggle="tab" href="#design-yeast">Design in S. Cerevisiae</a></li>
 
    <li><a data-toggle="tab" href="#background">Background</a></li>
 
  </ul>
 
 
</div>
 
</div>
  

Revision as of 11:10, 16 September 2015

EPFL 2015 iGEM bioLogic Logic Orthogonal gRNA Implemented Circuits EPFL 2015 iGEM bioLogic Logic Orthogonal gRNA Implemented Circuits

Project description

Bio LOGIC in 12 questions

What does Bio LOGIC stand for?

It stands for “Bio Logic Orthogonal gRNA-Implemented Circuit”. In a few words, we are working on implementing digital-like circuits in cells. This would basically allow intracellular computing.

Don’t biological circuits already exist?

Yes. However, difficulties in the multiplication and chaining of logic elements has hindered the complexification of these circuits. To overcome these limitations, an ideal in vivo logic element should be modular, reusable and orthogonal - i.e avoiding cross-talk with its host organism and the other elements of the circuit.

So, what’s different about your system?

We can avoid some of these issues by making a completely synthetic biological circuit. This is what we are doing by using the newly discovered dCas9 as a synthetic transcription factor.

How can dCas9 be used as a transcription factor?

Well, you know CRISPR-Cas9, the RNA-guided DNA endonuclease, right? We are using dCas9, the catalytically dead version of Cas9, which lacks the ability to cleave DNA. We will fuse dCas9 to a RNA Polymerase (RNAP) recruiting element. Depending on where it binds, this complex will either activate or inhibit transcription.

How does this activation/inhibition system work?

When dCas9 binds at an optimal distance upstream from the promoter, the RNAP recruiting elements with which it is fused will, in fact, recruit RNAP, thus activating the transcription of the gene that is controlled by this promoter. However, when dCas9 binds on the promoter, it will sterically hinder RNAP from binding at the transcription start site, thus inhibiting the transcription of the gene.

How do you guide the dCas9 to activating/inhibiting region?

dCas9 works just like Cas9, meaning it is RNA-guided. Small guide RNA (sgRNA) and dCas9 can form a complex. This complex will bind tightly to a DNA sequence which is complementary to the sgRNA. So we can guide dCas9 to activating or inhibiting regions of a promoter by producing sgRNAs complementary to these sequences.

Can a sgRNA-dCas9 complex activate one region and inhibit another in the same cell?

Yes, a sgRNA-dCas9 complex will bind to any sequence that is complementary to the sgRNA. So, if the activating region and the inhibiting region of different promoters have the same sequence, two identical sgRNA-dCas9 complexes can bind both at the same time. This is also why we have to be careful not to target regions that are present in the genome of the host organism, to not interfere with cell’s standard function.

What happens if the activating region and the inhibiting region of the same promoter are bound by dCas9 at the same time?

That is a very good question! It was shown that inhibition is dominant in yeast (S. Cerevisiae) [Tunable and multifunctional eukaryotic transcription factors based on CRISPR/Cas, F. Farzadfard, S. D. Perli, T. K. Lu].This means that, if both activating and inhibiting regions are bound, the transcription of the gene will be inhibited. One goal of our project is to find out if this is also the case in bacteria (E. Coli). We will also test our system in yeast.

How are you going to use this to make biological circuits?

Because of time constraints, we won’t be able to make a real biologic circuit. We aim to make and characterize a biological equivalent to the simplest element in a digital circuit, a transistor. Transistors function like switches for electric current. Our bio-transistors work like switches for the transcription of a gene and can be assembled to form biological circuits.

What does your bio-transistor look like?

The bio-transistor is simply a gene with a promoter. We insert this synthetic sequence in a cell, along with a gene producing dCas9 fused to the RNAP recruiting element and the sequence that produces an sgRNA complementary to either the activating or the inhibiting region of the promoter. dCas9 and the sgRNA are produced, they form a complex which binds to the activating or inhibiting region of the promoter, thus “turning the gene on or off”.

How do you make biological circuits from bio-transistors?

Well, digital circuits are made out of logic gates, elements that perform basic logic functions (AND, OR, NOT, NOR, NAND, XOR, etc.), and logic gates are made out of transistors. Our idea is to assemble our bio-transistors into logic gates. By linking the output of one logic gate to the input of another one, we can make biological circuits that function in the same way as a digital circuit.

Sounds cool! But what can this be used for?

A single transistor is not very useful. However, by assembling a certain number of bio-transistors, we could make complex biological circuits that would have different outputs depending on many inputs. For example, we could make complex biosensors by building a circuit that is activated by the presence of a specific combination of molecules, or that has a different response for different combinations of molecules. This is only one example among the many applications of biological circuits.

Find out more about how we implemented our system in E. coli and in S. cerevisiae or about what’s already been done with biological circuits and the publications that inspired us, or check out our results.

Design in E. Coli

To implement Bio LOGIC, we need to use dCas9 fused to a RNAP recruiting element. Based on Bikard [reference here], we fused the w (omega) subunit of RNAP to dCas9.

The "transcription factor": dCas9-w

Design in yeast

Background

EPFL 2015 iGEM bioLogic Logic Orthogonal gRNA Implemented Circuits

NOT PROOFREAD